Citius Pharmaceuticals, Inc. reports

Company location: Cranford, NJ
Fiscal year end: 30 September

Citius Pharmaceuticals, Inc. has filed 629 SEC EDGAR filings since 23 Nov 2010

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-225 of 629 matching filings.

Per page

25

Current page

9

8-K File 001-38174

CURRENT REPORT

Filing date: 06 Dec 2021
Reporting date: 06 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Oct 2021
Reporting date: 11 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 07 Sep 2021
Reporting date: 01 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 12 Aug 2021
Reporting date: 12 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38174

QUARTERLY REPORT

Filing date: 12 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 Jul 2021
Reporting date: 22 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-217956

PROSPECTUS

Filing date: 23 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-217956

EFFECT filing

Filing date: 08 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 07 Jul 2021
Reporting date: 07 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-217956

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date: 02 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .